US 11000562
Use of isolated fractions of mastic gum for treating optic neuropathy
granted A61KA61K2236/00A61K36/22
Quick answer
US patent 11000562 (Use of isolated fractions of mastic gum for treating optic neuropathy) held by REGENERA PHARMA LTD. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERA PHARMA LTD.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2236/00, A61K36/22, A61K47/06, A61K47/10